Eli Lilly Announces World's First Potential COVID-19 Antibody Treatment Study
Eli Lilly's Corporate Headquarters in Indianapolis. The company announced Monday it had started the world's first COVID-19 antibody treatment in humans study. (Lauren Chapman/IPB N…